The latest gynaecological cancer news
In an exploratory study of nearly 10,000 women with no history of cancer, researchers evaluating a multi-cancer…
In a first-time disclosure of IPN60090, a small-molecule inhibitor of the metabolic enzyme glutaminase (GLS1),…
Women who don’t survive a rare and aggressive uterine cancer called uterine serous carcinoma, have…
Many cells in the inner lining of the uterus carry ‘cancer-driving’ mutations that frequently arise…
An international research team, led by scientists from Mater Research—The University of Queensland, have discovered…
A sponge found in Manado Bay, Indonesia, makes a molecule called manzamine A, which stops…
An international study involving researchers from QIMR Berghofer Medical Research Institute has found women who…
Gardnerella bacteria in the cervicovaginal microbiome may serve as a biomarker to identify women infected with…
In patients with advanced ovarian cancer, a combination of drugs known as immune checkpoint inhibitors…
Combining a therapeutic vaccine for human papilloma virus (HPV) with two standard chemotherapy drugs may…